European pharma shares drop after Trump threatens more tariffs
FILE PHOTO: A view shows a Novo Nordisk sign outside their office in Bagsvaerd, on the outskirts of Copenhagen, Denmark, July 14, 2025. REUTERS/Tom Little/File Photo
LONDON (Reuters) -Shares in Europe's biggest pharma companies fell in early trading on Friday, after U.S. President Donald Trump unveiled a new round of punishing tariffs, including 100% duties on branded drugs.
The announcements, made on Truth Social, did not include details about whether the new levies would apply on top of national tariffs or whether economies with trade deals such as the European Union and Japan would be exempted. Tokyo said it was still analyzing the potential impact of the new measures.
Shares in Novo Nordisk, Roche, Novartis and Astrazeneca were down betweeen 1.8% and 2% on the Tradegate platform.
(Reporting by Amanda Cooper; Editing by Anna Pruchnicka)
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Italy fines WINDTRE €1.7 million over data breaches
- US agency denies Tesla petition to avoid recall fix over headlight issue
- Factbox-How Uber, Delivery Hero and rivals stack up in global food delivery
Create E-mail Alert Related Categories
ReutersRelated Entities
Donald J. TrumpSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share